1. Home
  2. KNSA vs OLN Comparison

KNSA vs OLN Comparison

Compare KNSA & OLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • OLN
  • Stock Information
  • Founded
  • KNSA 2015
  • OLN 1892
  • Country
  • KNSA United Kingdom
  • OLN United States
  • Employees
  • KNSA N/A
  • OLN N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • OLN Major Chemicals
  • Sector
  • KNSA Health Care
  • OLN Industrials
  • Exchange
  • KNSA Nasdaq
  • OLN Nasdaq
  • Market Cap
  • KNSA 2.6B
  • OLN 2.6B
  • IPO Year
  • KNSA 2018
  • OLN N/A
  • Fundamental
  • Price
  • KNSA $35.92
  • OLN $24.97
  • Analyst Decision
  • KNSA Strong Buy
  • OLN Hold
  • Analyst Count
  • KNSA 6
  • OLN 14
  • Target Price
  • KNSA $40.83
  • OLN $25.50
  • AVG Volume (30 Days)
  • KNSA 392.6K
  • OLN 2.4M
  • Earning Date
  • KNSA 10-28-2025
  • OLN 10-23-2025
  • Dividend Yield
  • KNSA N/A
  • OLN 3.20%
  • EPS Growth
  • KNSA N/A
  • OLN N/A
  • EPS
  • KNSA 0.07
  • OLN N/A
  • Revenue
  • KNSA $529,332,000.00
  • OLN $6,663,300,000.00
  • Revenue This Year
  • KNSA $37.21
  • OLN $5.76
  • Revenue Next Year
  • KNSA $11.99
  • OLN $2.79
  • P/E Ratio
  • KNSA $542.28
  • OLN N/A
  • Revenue Growth
  • KNSA 56.18
  • OLN 1.49
  • 52 Week Low
  • KNSA $17.82
  • OLN $17.66
  • 52 Week High
  • KNSA $37.34
  • OLN $49.60
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 60.14
  • OLN 58.82
  • Support Level
  • KNSA $35.29
  • OLN $24.75
  • Resistance Level
  • KNSA $37.34
  • OLN $26.32
  • Average True Range (ATR)
  • KNSA 1.00
  • OLN 1.07
  • MACD
  • KNSA -0.15
  • OLN -0.05
  • Stochastic Oscillator
  • KNSA 65.30
  • OLN 50.46

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About OLN Olin Corporation

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

Share on Social Networks: